It is expected that a price bounce should occur soon.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PNTG advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .
PNTG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on December 03, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on PNTG as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for PNTG turned negative on December 05, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PNTG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PNTG entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PNTG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.303) is normal, around the industry mean (4.577). P/E Ratio (45.727) is within average values for comparable stocks, (71.885). Projected Growth (PEG Ratio) (1.810) is also within normal values, averaging (1.595). PNTG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.026). P/S Ratio (1.115) is also within normal values, averaging (21.067).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PNTG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
a company, which engages in the provision of healthcare services
Industry MedicalNursingServices
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LSFLX | 13.11 | 0.13 | +1.00% |
Lord Abbett Focused Large Cap Value R4 | |||
RLESX | 25.56 | 0.22 | +0.87% |
Russell Inv US Small Cap Equity S | |||
DQEIX | 11.57 | 0.07 | +0.61% |
BNY Mellon Global Equity Income - I | |||
TQAAX | 42.73 | 0.19 | +0.45% |
T. Rowe Price Integrated US Sm Gr Eq Adv | |||
PRASX | 16.81 | 0.04 | +0.24% |
T. Rowe Price New Asia |
A.I.dvisor indicates that over the last year, PNTG has been loosely correlated with NHC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PNTG jumps, then NHC could also see price increases.
Ticker / NAME | Correlation To PNTG | 1D Price Change % | ||
---|---|---|---|---|
PNTG | 100% | +0.29% | ||
NHC - PNTG | 43% Loosely correlated | -1.72% | ||
AVAH - PNTG | 41% Loosely correlated | +1.33% | ||
SEM - PNTG | 39% Loosely correlated | +4.38% | ||
ENSG - PNTG | 37% Loosely correlated | -0.39% | ||
ADUS - PNTG | 37% Loosely correlated | +1.39% | ||
More |